Sign in
4

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-21-005571

10% owner bought 3,000 shares at $16.25 ($48,750)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cambrian BioPharma Inc 10% owner 2021-03-02 Purchase +3,000 $16.25 $48,750 4,771,794 D: show line 1 in the form
Open-market purchases · 3,000 sh · avg $16.25 · $48,750
Loading xslF345X03/doc1.xml…